Dementia CaregiversNCT07845032
ACT for Dementia Caregivers: Evaluating Psychological Flexibility as the Mechanism to Improve Psychological Distress
A study testing ACT for Caregivers in people with Dementia Caregivers, run by Utah State University at 1 site in United States.
Trial summary
Over 55 million people worldwide have dementia, and in the United States, 80% of people with dementia are cared for at home by family. While family caregivers report positive aspects of their role, many report depressive and anxiety symptoms, and global distress. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dementia Caregivers
- What is being tested?
- ACT for Caregivers
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Jul 2026to 31 May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Family caregiver to a person with dementia or with significant memory loss that impacts their everyday life
- Distressed from their caregiving role as measured by a score of 4+ on a single item "How distressed are you by caring for your family member?" (1 not at all to 10 extremely).
- Interested in taking part in an online self-guided six-session program with multiple assessments
- Able to read/write in English
- Have access to a computer/smartphone/tablet with internet.
- Live in the United States
Who cannot join
- No additional exclusion criteria beyond if participants do not meet one or more of the inclusion criteria.
- Have a phone number from a land-line or cellular carrier. This latter requirement is to reduce fraudulent participants, who in prior studies all provided IP-based numbers (IP-based numbers are identifiable via free online software). Of note, cohabiting with the care receiver is NOT a requirement, as distress can occur in non-cohabiting care dyads.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Heather H Kelley, PhD contact
United States1 site, 1 recruiting
- Recruiting
Utah State University
Logan, Utah, 84322
Lindy Stant, B.S., 435-797-2905, lindy.stant@usu.edu
Elizabeth B Fauth, PhD
About this study
Official title: Online Self-guided ACT for Dementia Caregivers: Evaluating Psychological Flexibility as the Mechanism to Improve Psychological Distress
Over 55 million people worldwide have dementia, and in the United States, 80% of people with dementia are cared for at home by family. While family caregivers report positive aspects of their role, many report depressive and anxiety symptoms, and global distress. There is vast heterogeneity in caregivers' experiences, dependent on biopsychosocial risk/contextual factors, and secondary challenges (financial concerns, work disturbances, etc.). While an array of empirically validated interventions can support dementia caregivers, interventions utilizing a transdiagnostic approach can yield improvements in comorbid symptomatology by addressing common underlying mechanisms of chronic or acute conditions, and mechanisms that promote living well with stress.
Acceptance and Commitment Therapy (ACT) is a modern ("third wave") Cognitive Behavioral Therapy (CBT) that addresses clinically significant, or subclinical levels of anxiety, depression, and a myriad of other conditions. The transdiagnostic mechanism in ACT involves increasing psychological flexibility, by changing the impact of negative thoughts and feelings, without having to change the frequency or form of their occurrence. ACT teaches individuals how to engage with painful/stressful experiences and respond with behaviors aligned with their personal values. Across 20 meta-analyses (n=12,477) of ACT clinical trials, ACT is efficacious in improving depression, anxiety, distress, and more. In dementia caregivers, therapist-guided ACT has also yielded improvements in various aspects of psychological distress.
Read more
Despite the evidence for ACT improving dementia caregivers' mental health, therapist-delivered interventions are more costly, less convenient, and less "scalable" (i.e. reaching fewer individuals). Online self-guided therapies can be equally effective as face-to-face therapy and are effective for caregivers. In non-caregivers, ACT has been adapted to online, self-guided delivery, demonstrating effective therapeutic results. The investigators' preliminary (Stage I and II) studies provide evidence that ACT is feasible and acceptable in an online, self-guided program tailored to dementia caregivers, and have identified preliminary efficacy in improving the proposed mechanism of change, psychological flexibility, and outcomes of caregiver depression. There is, however, a substantial need to understand if/how psychological flexibility and engagement with ACT for Caregivers work mechanistically to reduce psychological distress for users (with distress defined by the DASS-21 as symptoms of depression, anxiety, and stress). This proposal is responding to the EMBRACE call for mechanism-focused dementia care and caregiver support intervention development, targeting the level of the caregiver. Guided by the Checklist for Investigating Mechanisms in Behavior-change Research (CLIMBR), this Stage II (N=120) waitlist randomized control trial (RCT) will:
- Determine the efficacy of an online, self-guided ACT for Caregivers program for improving dementia caregiver psychological distress. The investigators hypothesize that treatment-to-waitlist condition will be associated with reductions in psychological distress over time, pre-to-post intervention, where those in the treatment group will show greater improvements in distress compared to those in the waitlist condition.
- Determine if and how treatment effects explain changes in psychological flexibility and how changes to psychological flexibility account for changes in distress. The investigators hypothesize that caregivers in the treatment group will show improvements in psychological flexibility, above and beyond, those in the control group. Further, the investigators hypothesize that these changes to psychological flexibility will account for changes in distress.
- Determine if and how user adherence to the program at time 2 (i.e., number of online sessions completed) is associated with the proposed mechanism, psychological flexibility (at time 3). The investigators hypothesize that, within the treatment group, greater adherence to ACT modules will be associated with greater psychological flexibility and greater improvements in distress.
With this Stage II study, the investigators examine if the proposed mechanism of change in ACT for Caregivers -- psychological flexibility -- influences changes in caregivers' distress. The investigators also explore how user adherence to the program is associated with changes in both the mediator and the outcome. Gathering evidence on the mechanism of change and intervention adherence is a necessary step in establishing ACT for Caregivers as an empirically validated intervention for dementia caregivers.
Read the detailed description
Design of the current study:
The proposed study has several design aspects that should be identified and justified. It is a waitlist randomized controlled trial, allowing us a rigorous experimental design for between-person comparisons and robust assessments of mediation between treatment (Tx) and waitlist control (W), while also allowing all participants to get the treatment, and facilitating a larger sample size for within person analyses. See Figure 3 for the timing and delivery of the study assessments.
Participants Power analysis: Using RStudio, the investigators stimulated models using the lme4 package and mediation package. Based on pilot data, the investigators assumed a medium effect across all variables (i.e., X --> M, X--> Y, and M --> Y) and a strong intraclass correlation (ICC = .6). The investigators ran 1000 simulations and found that using a sample size of 120 participants (60 Tx, 60 in waitlist), the investigators were able to identify significant average causal mediation effect, significant average direct effect, a significant total effect, and that the proportion mediated was significant (all ps < .05). The estimated proportion mediated was approximately 25% (95% CI: [10%,57%]), suggesting the ability to identify meaningful indirect pathways from X to Y via M. These results indicate that a sample size of 120 participants provides adequate power for the mediation analyses. Given that the mediation model represents the most complex analysis in the study and accounts for individual pathways, this sample size will be sufficient to power the direct between- and within-person analyses outlined in both Aim 1 and Aim 2. Based on the pilot study where a 27.7% attrition rate was observed between the first and second timepoints, the investigators will aim to recruit 153 individuals into the study to arrive at the desired sample size of 120.
Recruitment: Family caregivers will be recruited through IRB-approved materials. The investigators will utilize the recruitment methods deemed most effective in the prior Stage I and II studies. Of note, the prior Stage II study recruited 90+ participants across nine months in 2023. The investigators will advertise via 1) the Alzheimer's Association's TrialMatch program, 2) social media and print/online stories distributed by Utah State University, 3) health fairs and events such as the Walk to End Alzheimer's, and 4) existing listservs of community partners. These partners include Utah's Alzheimer's Disease and Related Dementia Coordinating Council (Utah Department of Health and Human Services), and USU's Institute for Disability Research, Policy, and Practice. New approaches for the current study will include accessing the research registry of USU's Alzheimer's Disease and Dementia Research Center, and using the newly-established USU Dementia Caregiver Clinic, which brings in an estimated 80 caregivers per year. The investigators also will utilize the Participant Manager's time to actively recruit out of state to increase geographic and ethnic/racial heterogeneity. The investigators will request that the study opportunity be distributed via the 15 newsletters representing NIA supported ADRC's. With IRB approval, the investigators can request to access the Participant Resource Pool Michigan Center for Urban African American Aging Research (MCUAAAR).
Retention: Participants will receive weekly reminder emails to complete a session, on a day of their choosing. If a participant has lapsed in engagement for two weeks, they will receive a reminder phone call. If attrition occurs, the data from any of the assessments or responses in treatment sessions attended are still useful; as described in the analysis section, an intent to treat analytic approach will be used.
ACT for Caregivers Intervention: The ACT for Caregivers online, self-guided intervention is intended to improve psychological flexibility (via learning to be more open, aware, and engaged), and to improve psychological distress. Participants access 6 sessions (each corresponding to one or more tenets of psychological flexibility), which they work through in order, asynchronously at their own pace, at home. Participants are encouraged (but not mandated) to complete one session per a week over six weeks, with sessions taking 20-40 minutes to complete.
Analyses:
An 'intent to treat' approach will be employed for all participants in the study. Analyses will be completed using Stata 18 (data cleaning) and R 4.0.0 or higher (lme4, nlme). A linear mixed-model will be used, where measurement occasions (Level 1) are nested within individuals (Level 2); treatment condition will be a Level 2 predictor that tests differences between the treatment and waitlist groups from T1 to T3. As observations (Level 1) are nested within individuals' (Level 2) over time, the investigators will employ mediation analyses within a mixed modeling framework. As an RCT examining psychological flexibility (putative mediator = M) as a mechanism underlying the effects of the ACT intervention (intervention = X) on reductions in caregiver psychological distress (outcome = Y), the investigators will conduct the following analyses, consistent with the Checklist for Investigating Mechanisms in Behavior-change Research (CLIMBR).
To assess aim 1, Model 1 will be used to investigate whether participants assigned to treatment with the ACT intervention exhibit decreased psychological distress relative to wait-list control participants, establishing the CLIMBR X --> Y path. To assess aim 2, Model 2 will extend Model 1 to include psychological flexibility as a mediator (M), to evaluate the CLIMBR X --> M and X --> M --> Y linkages articulating the extent to which ACT intervention-related changes in distress are mediated by (increased) psychological flexibility.
Mediation with be formally evaluated by percent reduction in the X --> Y association, tests of indirect effects, and computation of mediator effect sizes in RCTs. Supplemental analyses will consider the subcomponents of psychological flexibility, open, aware, and engaged, to explore the specific dimension(s) driving ACT-related change in psychological distress. Further, chi-square tests of nested model comparisons, evaluating model fit when constraining the magnitude of psychological flexibility effects to be equal, will be employed to determine differences in the magnitude of psychological flexibility components as mediating mechanisms. The investigators will also consider false discovery rates to evaluate potential spurious associations.
To assess aim 3, the investigators will investigate the role of program adherence in associations between psychological flexibility and caregiver psychological distress. The investigators will regress changes in T1 --> T2 and T1 --> T3 psychological flexibility on the number of sessions completed at T2, the operant index of adherence (# sessions completed 75 percent or more), to determine any modulation of effect by adherence. All item-level missingness will be treated using full information maximum likelihood (FIML).
- Conditions
- Dementia Caregivers
- Being tested
- ACT for Caregivers
- Keywords
- dementia, caregiving, acceptance and commitment therapy, digital mental health intervention, psychological flexibility
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ACT for CaregiversBehavioural
ACT for Caregivers is a self-guided digital mental health intervention intended to improve psychological flexibility (via learning to be more open, aware, and engaged), and to improve psychological distress. Participants access 6 sessions (each corresponding to one or more tenets of psychological flexibility), which they work through in order, asynchronously at their own pace, at home. Participants are encouraged (but not mandated) to complete one session per a week over six weeks, with sessions taking 20-40 minutes to complete.
| Study group | Role | What they receive |
|---|---|---|
| Treatment Group | Experimental | The treatment group will immediately receive access to the intervention following completion of the baseline survey. Receives: Behavioral: ACT for Caregivers |
| Waitlist Group | Experimental | This group will not receive the intervention until 12 weeks post baseline Receives: Behavioral: ACT for Caregivers |
What is being measured
The primary outcome is the main question the study is designed to answer.
Depression, Anxiety, and Stress Scale (DASS-21)
Depression, Anxiety, and Stress Scale (DASS-21) will be used to assess caregiver's overall psychological distress
Measured: The DASS-21 will be assessed at baseline, 6-week posttest, and 12-week follow-up.
Secondary outcomes (2)
Zarit Burden Interview-6 (ZBI-6)
The Zarit Burden Interview-6 (ZBI-6) is a 6-item scale designed to assess perceived caregiver burden and strain associated with providing care. Items assess the impact of caregiving on areas such as personal time, relationships, health, and emotional well-being. Responses range from 0 (never) to 4 (nearly always), with higher scores indicating greater caregiver burden
Measured: The ZBI-6 will be completed at baseline, 6-week posttest, and 12-week follow-up.
Positive Aspects of Caregiving Scale-6 (PACS-6)
The Positive Aspects of Caregiving Scale-6 (PACS-6) is a 6-item scale designed to assess positive perceptions and benefits associated with the caregiving experience, such as feeling useful, appreciated, needed, and more confident. Responses range from 1 (disagree a lot) to 5 (agree a lot), with higher scores indicating greater perceived positive aspects of caregiving.
Measured: The PACS-6 will be completed at baseline, 6-week posttest, and 12-week follow-up.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2026
- Study start20 Jul 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion31 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Dementia CaregiversStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- All participants will receive the same intervention, but half of participants will be randomly assigned to a waitlist condition and wait 10 weeks before receiving the program.
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Utah State University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Responsible party
- Principal investigator, Elizabeth Fauth, Utah State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07845032
- Sponsor's protocol ID
- 1P30AG086642
- Other IDs
- 5P30AG086642-02
- Status last verified
- Sep 2026
- First submitted
- 14 Sep 2026
- Last updated
- 28 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No identifying data will be shared outside of the IRB approved study team.
Publications
Fauth EB, Novak JR, Levin ME. Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers. Aging Ment Health. 2022 Aug;26(8):1620-1629. doi: 10.1080/13607863.2021.1942432. Epub 2021 Jul 7.
PubMed 34233133
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Online Self-guided ACT for Dementia Caregivers: Evaluating Psychological Flexibility as the Mechanism to Improve Psychological Distress
- ClinicalTrials.gov ID
- NCT07845032
- Acronym / sponsor ID
- 1P30AG086642
- Conditions
- Dementia Caregivers
- Keywords
- dementia, caregiving, acceptance and commitment therapy, digital mental health intervention, psychological flexibility
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Utah State UniversityUniversity, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Study start
- 20 Jul 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 May 2028 (estimated)
- First posted
- 28 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Over 55 million people worldwide have dementia, and in the United States, 80% of people with dementia are cared for at home by family. While family caregivers report positive aspects of their role, many report depressive and anxiety symptoms, and global distress. There is vast heterogeneity in caregivers' experiences, dependent on biopsychosocial risk/contextual factors, and secondary challenges (financial concerns, work disturbances, etc.). While an array of empirically validated interventions can support dementia caregivers, interventions utilizing a transdiagnostic approach can yield improvements in comorbid symptomatology by addressing common underlying mechanisms of chronic or acute conditions, and mechanisms that promote living well with stress.
Acceptance and Commitment Therapy (ACT) is a modern ("third wave") Cognitive Behavioral Therapy (CBT) that addresses clinically significant, or subclinical levels of anxiety, depression, and a myriad of other conditions. The transdiagnostic mechanism in ACT involves increasing psychological flexibility, by changing the impact of negative thoughts and feelings, without having to change the frequency or form of their occurrence. ACT teaches individuals how to engage with painful/stressful experiences and respond with behaviors aligned with their personal values. Across 20 meta-analyses (n=12,477) of ACT clinical trials, ACT is efficacious in improving depression, anxiety, distress, and more. In dementia caregivers, therapist-guided ACT has also yielded improvements in various aspects of psychological distress.
Despite the evidence for ACT improving dementia caregivers' mental health, therapist-delivered interventions are more costly, less convenient, and less "scalable" (i.e. reaching fewer individuals). Online self-guided therapies can be equally effective as face-to-face therapy and are effective for caregivers. In non-caregivers, ACT has been adapted to online, self-guided delivery, demonstrating effective therapeutic results. The investigators' preliminary (Stage I and II) studies provide evidence that ACT is feasible and acceptable in an online, self-guided program tailored to dementia caregivers, and have identified preliminary efficacy in improving the proposed mechanism of change, psychological flexibility, and outcomes of caregiver depression. There is, however, a substantial need to understand if/how psychological flexibility and engagement with ACT for Caregivers work mechanistically to reduce psychological distress for users (with distress defined by the DASS-21 as symptoms of depression, anxiety, and stress). This proposal is responding to the EMBRACE call for mechanism-focused dementia care and caregiver support intervention development, targeting the level of the caregiver. Guided by the Checklist for Investigating Mechanisms in Behavior-change Research (CLIMBR), this Stage II (N=120) waitlist randomized control trial (RCT) will:
- Determine the efficacy of an online, self-guided ACT for Caregivers program for improving dementia caregiver psychological distress. The investigators hypothesize that treatment-to-waitlist condition will be associated with reductions in psychological distress over time, pre-to-post intervention, where those in the treatment group will show greater improvements in distress compared to those in the waitlist condition.
- Determine if and how treatment effects explain changes in psychological flexibility and how changes to psychological flexibility account for changes in distress. The investigators hypothesize that caregivers in the treatment group will show improvements in psychological flexibility, above and beyond, those in the control group. Further, the investigators hypothesize that these changes to psychological flexibility will account for changes in distress.
- Determine if and how user adherence to the program at time 2 (i.e., number of online sessions completed) is associated with the proposed mechanism, psychological flexibility (at time 3). The investigators hypothesize that, within the treatment group, greater adherence to ACT modules will be associated with greater psychological flexibility and greater improvements in distress.
With this Stage II study, the investigators examine if the proposed mechanism of change in ACT for Caregivers -- psychological flexibility -- influences changes in caregivers' distress. The investigators also explore how user adherence to the program is associated with changes in both the mediator and the outcome. Gathering evidence on the mechanism of change and intervention adherence is a necessary step in establishing ACT for Caregivers as an empirically validated intervention for dementia caregivers.
Detailed description
Design of the current study:
The proposed study has several design aspects that should be identified and justified. It is a waitlist randomized controlled trial, allowing us a rigorous experimental design for between-person comparisons and robust assessments of mediation between treatment (Tx) and waitlist control (W), while also allowing all participants to get the treatment, and facilitating a larger sample size for within person analyses. See Figure 3 for the timing and delivery of the study assessments.
Participants Power analysis: Using RStudio, the investigators stimulated models using the lme4 package and mediation package. Based on pilot data, the investigators assumed a medium effect across all variables (i.e., X --> M, X--> Y, and M --> Y) and a strong intraclass correlation (ICC = .6). The investigators ran 1000 simulations and found that using a sample size of 120 participants (60 Tx, 60 in waitlist), the investigators were able to identify significant average causal mediation effect, significant average direct effect, a significant total effect, and that the proportion mediated was significant (all ps < .05). The estimated proportion mediated was approximately 25% (95% CI: [10%,57%]), suggesting the ability to identify meaningful indirect pathways from X to Y via M. These results indicate that a sample size of 120 participants provides adequate power for the mediation analyses. Given that the mediation model represents the most complex analysis in the study and accounts for individual pathways, this sample size will be sufficient to power the direct between- and within-person analyses outlined in both Aim 1 and Aim 2. Based on the pilot study where a 27.7% attrition rate was observed between the first and second timepoints, the investigators will aim to recruit 153 individuals into the study to arrive at the desired sample size of 120.
Recruitment: Family caregivers will be recruited through IRB-approved materials. The investigators will utilize the recruitment methods deemed most effective in the prior Stage I and II studies. Of note, the prior Stage II study recruited 90+ participants across nine months in 2023. The investigators will advertise via 1) the Alzheimer's Association's TrialMatch program, 2) social media and print/online stories distributed by Utah State University, 3) health fairs and events such as the Walk to End Alzheimer's, and 4) existing listservs of community partners. These partners include Utah's Alzheimer's Disease and Related Dementia Coordinating Council (Utah Department of Health and Human Services), and USU's Institute for Disability Research, Policy, and Practice. New approaches for the current study will include accessing the research registry of USU's Alzheimer's Disease and Dementia Research Center, and using the newly-established USU Dementia Caregiver Clinic, which brings in an estimated 80 caregivers per year. The investigators also will utilize the Participant Manager's time to actively recruit out of state to increase geographic and ethnic/racial heterogeneity. The investigators will request that the study opportunity be distributed via the 15 newsletters representing NIA supported ADRC's. With IRB approval, the investigators can request to access the Participant Resource Pool Michigan Center for Urban African American Aging Research (MCUAAAR).
Retention: Participants will receive weekly reminder emails to complete a session, on a day of their choosing. If a participant has lapsed in engagement for two weeks, they will receive a reminder phone call. If attrition occurs, the data from any of the assessments or responses in treatment sessions attended are still useful; as described in the analysis section, an intent to treat analytic approach will be used.
ACT for Caregivers Intervention: The ACT for Caregivers online, self-guided intervention is intended to improve psychological flexibility (via learning to be more open, aware, and engaged), and to improve psychological distress. Participants access 6 sessions (each corresponding to one or more tenets of psychological flexibility), which they work through in order, asynchronously at their own pace, at home. Participants are encouraged (but not mandated) to complete one session per a week over six weeks, with sessions taking 20-40 minutes to complete.
Analyses:
An 'intent to treat' approach will be employed for all participants in the study. Analyses will be completed using Stata 18 (data cleaning) and R 4.0.0 or higher (lme4, nlme). A linear mixed-model will be used, where measurement occasions (Level 1) are nested within individuals (Level 2); treatment condition will be a Level 2 predictor that tests differences between the treatment and waitlist groups from T1 to T3. As observations (Level 1) are nested within individuals' (Level 2) over time, the investigators will employ mediation analyses within a mixed modeling framework. As an RCT examining psychological flexibility (putative mediator = M) as a mechanism underlying the effects of the ACT intervention (intervention = X) on reductions in caregiver psychological distress (outcome = Y), the investigators will conduct the following analyses, consistent with the Checklist for Investigating Mechanisms in Behavior-change Research (CLIMBR).
To assess aim 1, Model 1 will be used to investigate whether participants assigned to treatment with the ACT intervention exhibit decreased psychological distress relative to wait-list control participants, establishing the CLIMBR X --> Y path. To assess aim 2, Model 2 will extend Model 1 to include psychological flexibility as a mediator (M), to evaluate the CLIMBR X --> M and X --> M --> Y linkages articulating the extent to which ACT intervention-related changes in distress are mediated by (increased) psychological flexibility.
Mediation with be formally evaluated by percent reduction in the X --> Y association, tests of indirect effects, and computation of mediator effect sizes in RCTs. Supplemental analyses will consider the subcomponents of psychological flexibility, open, aware, and engaged, to explore the specific dimension(s) driving ACT-related change in psychological distress. Further, chi-square tests of nested model comparisons, evaluating model fit when constraining the magnitude of psychological flexibility effects to be equal, will be employed to determine differences in the magnitude of psychological flexibility components as mediating mechanisms. The investigators will also consider false discovery rates to evaluate potential spurious associations.
To assess aim 3, the investigators will investigate the role of program adherence in associations between psychological flexibility and caregiver psychological distress. The investigators will regress changes in T1 --> T2 and T1 --> T3 psychological flexibility on the number of sessions completed at T2, the operant index of adherence (# sessions completed 75 percent or more), to determine any modulation of effect by adherence. All item-level missingness will be treated using full information maximum likelihood (FIML).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- All participants will receive the same intervention, but half of participants will be randomly assigned to a waitlist condition and wait 10 weeks before receiving the program.
| Arm | Type | Receives |
|---|---|---|
| Treatment Group | Experimental | Behavioral: ACT for CaregiversThe treatment group will immediately receive access to the intervention following completion of the baseline survey. |
| Waitlist Group | Experimental | Behavioral: ACT for CaregiversThis group will not receive the intervention until 12 weeks post baseline |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Family caregiver to a person with dementia or with significant memory loss that impacts their everyday life
- Distressed from their caregiving role as measured by a score of 4+ on a single item "How distressed are you by caring for your family member?" (1 not at all to 10 extremely).
- Interested in taking part in an online self-guided six-session program with multiple assessments
- Able to read/write in English
- Have access to a computer/smartphone/tablet with internet.
Key exclusion criteria (2 listed)
- No additional exclusion criteria beyond if participants do not meet one or more of the inclusion criteria.
- Have a phone number from a land-line or cellular carrier. This latter requirement is to reduce fraudulent participants, who in prior studies all provided IP-based numbers (IP-based numbers are identifiable via free online software). Of note, cohabiting with the care receiver is NOT a requirement, as distress can occur in non-cohabiting care dyads.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ACT for CaregiversACT for Caregivers is a self-guided digital mental health intervention intended to improve psychological flexibility (via learning to be more open, aware, and engaged), and to improve psychological distress. Participants access 6 sessions (each corresponding to one or more tenets of psychological flexibility), which they work through in order, asynchronously at their own pace, at home. Participants are encouraged (but not mandated) to complete one session per a week over six weeks, with sessions taking 20-40 minutes to complete. | Behavioural | Treatment Group, Waitlist Group |
Primary outcome
Depression, Anxiety, and Stress Scale (DASS-21)
Time frame: The DASS-21 will be assessed at baseline, 6-week posttest, and 12-week follow-up.
Depression, Anxiety, and Stress Scale (DASS-21) will be used to assess caregiver's overall psychological distress
2 secondary outcomes
Zarit Burden Interview-6 (ZBI-6)
Time frame: The ZBI-6 will be completed at baseline, 6-week posttest, and 12-week follow-up.
Positive Aspects of Caregiving Scale-6 (PACS-6)
Time frame: The PACS-6 will be completed at baseline, 6-week posttest, and 12-week follow-up.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2026.
- Background: PubMed 34233133Fauth EB, Novak JR, Levin ME. Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers. Aging Ment Health. 2022 Aug;26(8):1620-1629. doi: 10.1080/13607863.2021.1942432. Epub 2021 Jul 7.
- Individual participant dataSharing planned: No. No identifying data will be shared outside of the IRB approved study team.
Related trials for Dementia Caregivers
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Active, not recruiting
Health enSuite Caregivers: an App-based Treatment for Distressed Caregivers of Persons With Moderate Dementia
Caregiver Burnout
Not yet recruiting
Music Listening for Chronic Pain in Adults With Early-Stage Dementia
Chronic Pain, Alzheimer Disease
Not yet recruiting
A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement
Memory Disorders, Mild Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Heather H Kelley, PhD contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ACT for Caregivers in people with Dementia Caregivers, run by Utah State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elizabeth B. Fauth, PhD (435-797-1989, beth.fauth@usu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Depression, Anxiety, and Stress Scale (DASS-21) (time frame: The DASS-21 will be assessed at baseline, 6-week posttest, and 12-week follow-up.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07845032, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.